Literature DB >> 19111567

Purification and characterization of a novel lectin from the toxic wild mushroom Inocybe umbrinella.

J K Zhao1, H X Wang, T B Ng.   

Abstract

From the dried fruiting bodies of the toxic mushroom Inocybe umbrinella, a novel lectin with a molecular mass of 17 kDa has been isolated with about 160-fold purification. The purification protocol comprised ion exchange chromatography on DEAE-cellulose, and CM-cellulose, and gel filtration on Superdex 75. Among the carbohydrates tested, raffinose, d-melibiose, alpha-lactose and d(+)-galactose could inhibit the hemagglutinating activity of the lectin. The hemagglutinating activity was stable between 10 and 60 degrees C, in 12.5-100mM HCl, and in 50mM NaOH. The hemagglutinating activity was inhibited by Ca(2+), Mn(2+)and Mg(2+) ions, but was unaffected by Fe(3+), Zn(2+) and Al(3+) ions. The lectin inhibited HIV-1 reverse transcriptase with an IC(50) of 4.7+/-0.2 microM. Proliferation of tumor cells including hepatoma HepG2 cells and breast cancer MCF7 cells was inhibited by the lectin with an IC(50) of 3.5+/-0.2 microM and 7.4+/-0.3 micoM, respectively. The lectin has a unique N-terminal amino acid sequence, DGVLATNAVA. It did not exhibit antifungal activity. The present report is the first on an Inocybe lectin and represents one of the very few reports on lectins from toxic mushrooms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19111567     DOI: 10.1016/j.toxicon.2008.12.009

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  17 in total

Review 1.  Plant as a plenteous reserve of lectin.

Authors:  A G Ingale; A U Hivrale
Journal:  Plant Signal Behav       Date:  2013-10-01

2.  A novel lectin with highly potent antiproliferative and HIV-1 reverse transcriptase inhibitory activities from the edible wild mushroom Russula delica.

Authors:  Shuang Zhao; Yongchang Zhao; Shuhong Li; Jingkun Zhao; Guoqing Zhang; Hexiang Wang; Tzi Bun Ng
Journal:  Glycoconj J       Date:  2010-02       Impact factor: 2.916

Review 3.  Opportunistic invasive fungal pathogen Macrophomina phaseolina prognosis from immunocompromised humans to potential mitogenic RBL with an exceptional and novel antitumor and cytotoxic effect.

Authors:  P Arora; N Dilbaghi; A Chaudhury
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-08       Impact factor: 3.267

4.  A potent mitogenic lectin from the mycelia of a phytopathogenic fungus, Rhizoctonia bataticola, with complex sugar specificity and cytotoxic effect on human ovarian cancer cells.

Authors:  Nagaraja N Nagre; Vishwanath B Chachadi; Palaniswamy M Sundaram; Ramachandra S Naik; Radha Pujari; Padma Shastry; Bale M Swamy; Shashikala R Inamdar
Journal:  Glycoconj J       Date:  2010-03-22       Impact factor: 2.916

Review 5.  Lectins: production and practical applications.

Authors:  Sze Kwan Lam; Tzi Bun Ng
Journal:  Appl Microbiol Biotechnol       Date:  2010-10-03       Impact factor: 4.813

6.  A novel aspartic protease with HIV-1 reverse transcriptase inhibitory activity from fresh fruiting bodies of the wild mushroom Xylaria hypoxylon.

Authors:  Qing-Xiu Hu; Guo-Qing Zhang; Rui-Ying Zhang; Dan-Dan Hu; He-Xiang Wang; Tzi Bun Ng
Journal:  J Biomed Biotechnol       Date:  2012-05-17

Review 7.  Mushroom lectins: specificity, structure and bioactivity relevant to human disease.

Authors:  Mohamed Ali Abol Hassan; Razina Rouf; Evelin Tiralongo; Tom W May; Joe Tiralongo
Journal:  Int J Mol Sci       Date:  2015-04-08       Impact factor: 5.923

8.  Recent developments in mushrooms as anti-cancer therapeutics: a review.

Authors:  Seema Patel; Arun Goyal
Journal:  3 Biotech       Date:  2011-11-25       Impact factor: 2.406

9.  Rhizoctonia bataticola lectin (RBL) induces caspase-8-mediated apoptosis in human T-cell leukemia cell lines but not in normal CD3 and CD34 positive cells.

Authors:  Radha Pujari; Sachin M Eligar; Natesh Kumar; Srikanth Barkeer; Vishwanath Reddy; Bale M Swamy; Shashikala R Inamdar; Padma Shastry
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

10.  A novel hemagglutinin with antiproliferative activity against tumor cells from the hallucinogenic mushroom Boletus speciosus.

Authors:  Jian Sun; Tzi-Bun Ng; Hexiang Wang; Guoqing Zhang
Journal:  Biomed Res Int       Date:  2014-05-29       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.